Search Results 271-280 of 16264 for anti-TNF drugs

1. Naftifine (topical route) - Mayo Clinic

   Drug Interactions. Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an ...

2. Fulvestrant (intramuscular route) - Mayo Clinic

   It is also used to treat HR positive breast cancer that has progressed or worsened after hormonal therapy. Fulvestrant injection is also used together with ...

3. Antidepressants: Safe during pregnancy? - Mayo Clinic

   Medicines often are important for treating depression while pregnant. Weigh the risks and benefits with your health care team.

4. A Study to Evaluate the Effectiveness and Safety of TD-1473 in Crohn's Disease - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search tips. A ... anti-TNF anti-IL-12/IL-23 therapy, or anti ...

5. Medicine use in transplant recipients - Mayo Clinic

   https://www.kidney.org.uk/what-drugs-are-needed-after-transplantation. Accessed Oct. 28, 2024. Immunosuppressants (Anti-rejection medicines). National Kidney ...

6. Drugs and Supplements that Start with Z - Mayo Clinic

   Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “Z” to learn about drug side effects, proper use and ...

7. A Study to Evaluate Remicade (Infliximab) for the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection and are at an Increased Risk of Recurrence - Mayo Clinic

   ... treatment with adalimumab and/or certolizumab. Must undergo screening for HBV; Baseline CDAI < 200; Has adequate blood and liver test values. Exclusion Criteria.

8. Study finds lung transplant patients not given antifungal preventive drugs have higher risk of death

   Also, antifungal medications are expensive and can interact with other medications. Therefore, the health care team must monitor anti-fungal medications closely ...

9. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... [anti-TNF] agents) ≤ 2 weeks prior to registration. Note: Patients who have ...

10. Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer - Mayo Clinic

    ... anti-tumor necrosis factor [anti-TNF] agents) within 6 weeks prior to cycle 1 day 1: Patients who have received acute, low dose, systemic immunosuppressant ...